MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced its new uterine health education and awareness campaign Better is Possible™. Launching in New York, Los Angeles, Atlanta and Detroit, the campaign seeks to increase awareness about daily quality-of-life challenges such as heavy and disruptive periods, pelvic pain and fibroids, while also educating women about available treatment options. Heavy and disruptive periods, also known as abnorma ...

Hologic (HOLX) closed the most recent trading day at $72.12, moving +1.11% from the previous trading session. The stock's performance was ahead of the S&P 500's daily loss of 0.15%. Elsewhere, the Dow saw a downswing of 0.42%, while the tech-heavy Nasdaq appreciated by 0.09%.Prior to today's trading, shares of the medical device maker had gained 3.86% over the past month. This has lagged the Medical sector's gain of 6.58% and outpaced the S&P 500's gain of 3.5% in that time.Market participants will be close ...

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Shares of this medical device maker have returned +6.7% over the past month versus the Zacks S&P 500 composite's +2.9% change. The Zacks Medical - Instruments industry, to which Hologic belongs, has gained 6.1% over this period. Now the key question is: Where could the stock be headed in the near term?Although media ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today preliminary revenue results for its first fiscal quarter ended December 30, 2023. The Company expects to report total revenues of approximately $1,013.1 million, a decrease of (5.7%) compared to the prior year period, or (6.4%) in constant currency. These preliminary results exceed the Company’s most recent revenue guidance range of $960 to $985 million, provided on November 9, 2023. “Once again we delivered strong organic ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2024 on Thursday, February 1, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dialing (888) 394-8218 (in the United States and Canada) or +1 (773) 305-6853 (for international callers) and referencing access ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 1:30 p.m. Pacific Time. The presentation and Q&A session will be webcast live and may be accessed through a link on the Investors section of Hologic’s website at http://investors.hologic.com. The webcast will be available for 30 days following the event. About Hologic, Inc. Hologic, Inc. is an innovative medica ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 1:30 p.m. Pacific Time.The presentation and Q&A session will be webcast live and may be accessed through a link on the Investors section of Hologic’s website at http://investors.hologic.com. The webcast will be available for 30 days following the event.About Hologic, Inc.Hologic, Inc. is an innovative medical tech ...

FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 30, 2023 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 _________________________________________________ ...

Hologic, Inc. (NASDAQ:HOLX) Q4 2023 Earnings Call Transcript November 9, 2023 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Stephen MacMillan - Chairman, President and Chief Executive Officer Conference Call Participants Puneet Souda - Leerink Partners Jack Meehan - Nephron Research Derik De Bruin - Bank of America Patrick Donnelly - Citi Timothy Daley - Wells Fargo Anthony Petrone - Mizuho Group Casey Woodring - JPMorgan Navann Ty - BNP Paribas Exane Michael Matson - Needh ...

Hologic, Inc. (NASDAQ:HOLX) Q3 2023 Earnings Conference Call July 31, 2023 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Stephen MacMillan - Chairman, President and Chief Executive Officer Karleen Oberton - Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Michael Matson - Needham & Company Jack Meehan - Nephron Research Vijay Kumar - Evercore ISI Timothy Daley - Wells Fargo Tejas Savant - Morgan Stanley Puneet Souda - Leerink Partners Anthony Pet ...